Chemoimmunotherapy of human cancer: The need for a unified drug development program J. U. Gutterman Editorial Pages: 153 - 156
A randomized clinical trial of remission induction, consolidation, and chemo-immunotherapy maintenance in adult acute myeloblastic leukemia William R. VoglerAlfred A. BartolucciWriting Committee for Southeastern Cancer Study Group Original Papers Pages: 163 - 170
Further studies on the structural requirements of agents for immunotherapy of the guinea pig line-10 tumor E. RibiR. ToubianaR. Parker Original Papers Pages: 171 - 177
Immunotherapy of a guinea pig hepatoma with vaccines containing mycobacterial fractions H. J. RappE. YarkoniJ. T. Hunter Original Papers Pages: 179 - 181
Immunotherapy with allogeneic immune peritoneal cells activated by BCG or pyran copolymer Richard M. SchultzMichael A. ChirigosJoseph D. Papamatheakis Original Papers Pages: 183 - 187
Effect of treatment with the MER tubercle bacillus fraction on syngeneic plasma cell tumors of BALB/c mice Y. StuppN. MannyG. Izak Original Papers Pages: 189 - 193
A, B and H isoantigens in atypical oral epithelium R. StejskalP. H. LillI. Davidsohn Original Papers Pages: 195 - 199
In vivo anti-tumor immunity detected by leukocyte adherence inhibition T. G. GipsonW. J. Martin Original Papers Pages: 201 - 205
Progressive atrophy of the thymus in mice carrying Lewis lung carcinoma grafts Lasse EfskindTore GodalSian Høglo Short Communication Pages: 207 - 209
Comment on the loss of immunogenicity of tumor cells caused by freezing S. P. Leibo Letter To The Editor Pages: 211 - 213
Response to the letter to the editor G. L. BartlettJ. W. Kreider Letter To The Editor Pages: 213 - 213
